Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Fluid and Norepinephrine for Preventing AKI in Septic Shock
NCT07418541Not yet recruiting
- Sponsor
- Universitas Sumatera Utara
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of norepinephrine in septic shock, sponsored by Universitas Sumatera Utara. Primary endpoint: Occurrence of Acute Kidney Injury at 48 hours. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
norepinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT07418541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07418541.